ANCA相关性血管炎周围神经病变的基线预测因素:KEIO血管炎队列
该研究纳入111例新诊断、未治疗的活动性ANCA相关性血管炎患者,比较无周围神经病变、感觉神经病变和感觉运动神经病变三组的基线特征。EGPA患者周围神经病变发生率最高(84.6%),显著高于GPA(20.0%)和MPA(28.9%)(P<0.001)。EGPA患者基线嗜酸性粒细胞计数随神经病变严重程度呈阶梯式升高,或可用于预测周围神经病变及运动受累。
要点
- EGPA周围神经病变发生率84.6%,高于GPA的20.0%和MPA的28.9%(P<0.001)。
- EGPA基线嗜酸性粒细胞计数随神经病变严重程度阶梯式升高(P=0.004)。
- GPA和MPA中中性粒细胞与淋巴细胞比值随神经病变严重程度呈上升趋势,但差异无统计学意义。
核心结论
- 基线嗜酸性粒细胞计数可能是EGPA患者周围神经病变存在及运动受累的有用预测因素。
- 在GPA和MPA中,中性粒细胞驱动的炎症可能参与周围神经病变的发生。
研究设计与样本
- 纳入111例连续的新诊断、未治疗、活动性ANCA相关性血管炎患者。
- 比较无周围神经病变、感觉神经病变和感觉运动神经病变三组的基线特征。
- 分析按疾病亚型分层:EGPA、GPA和MPA。
主要发现
- EGPA患者周围神经病变发生率为84.6%,GPA为20.0%,MPA为28.9%(P<0.001)。
- EGPA患者基线嗜酸性粒细胞计数:无周围神经病变组2340/μL,感觉神经病变组4276/μL,感觉运动神经病变组11859/μL(P=0.004)。
- GPA和MPA患者中性粒细胞与淋巴细胞比值随周围神经病变严重程度呈上升趋势,但差异无统计学意义。
关键数值与推荐
- 预测EGPA周围神经病变的基线嗜酸性粒细胞计数最佳截断值为2468/μL(敏感性90%,特异性75%)。
- 预测EGPA感觉运动神经病变的基线嗜酸性粒细胞计数最佳截断值为6724/μL(敏感性80%,特异性71%)。
临床怎么用
- 在EGPA患者中,基线嗜酸性粒细胞计数可能有助于周围神经病变的早期风险分层。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Peripheral neuropathy affects quality of life in patients with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis. Early recognition and treatment initiation are essential to prevent irreversible nerve damage. The aim of this study was to identify baseline factors associated with peripheral neuropathy in ANCA-associated vasculitis. METHODS: A total of 111 consecutive patients with newly diagnosed, treatment-naïve, active ANCA-associated vasculitis were enrolled. Baseline characteristics were compared among the three groups: patients without peripheral neuropathy, with sensory neuropathy, and with sensorimotor neuropathy. Analysis was further stratified by disease subtypes (eosinophilic granulomatosis with polyangiitis, EGPA; granulomatosis with polyangiitis, GPA; microscopic polyangiitis, MPA). RESULTS: Patients with EGPA (84.6 %) were most prone to having peripheral neuropathy compared with GPA (20.0 %) and MPA (28.9 %) (P < 0.001). Among patients with EGPA, baseline eosinophil counts showed a stepwise increase with peripheral neuropathy severity: 2340/μL in patients without peripheral neuropathy, 4276/μL with sensory neuropathy, and 11,859/μL with sensorimotor neuropathy (P = 0.004). The most useful cutoff values of baseline eosinophil counts to predict peripheral neuropathy and sensorimotor neuropathy were 2468/μL (sensitivity 90 % and specificity 75 %) and 6724/μL (sensitivity 80 % and specificity 71 %), respectively. In patients with GPA and MPA, the neutrophil-to-lymphocyte ratio tended to rise with increasing peripheral neuropathy severity, although the difference was not statistically significant. CONCLUSION: Baseline eosinophil counts may be useful predictors for both the presence and motor involvement of peripheral neuropathy in patients with EGPA, highlighting their clinical utility and early risk stratification. In GPA and MPA, neutrophil-driven inflammation may contribute to peripheral neuropathy development.
引用
- Imai Y, Ishigaki S, Akiyama M, et al. Distinct predictors of peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitis: KEIO-vasculitis cohort. Semin Arthritis Rheum. 2025. PMID: 41273823. doi:10.1016/j.semarthrit.2025.152882
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。